Table 1 Patient demographic and tumor characteristics
Variables | Number of patients | Number of patients |
|---|---|---|
(%) | (%) | |
Control group | Nimotuzumab patients | |
Sex | ||
Male | 19 (50%) | 21 (65.6%) |
Female | 19 (50%) | 11 (34.4%) |
Race | ||
White | 31 (81.5%) | 27 (84.3%) |
Black | 1 (2.6%) | 2 (6.3%) |
Mixed | 6 (15.8%) | 3 (9.3%) |
Age | ||
Mean | 45.5 | 47.2 |
Median | 46.5 | 44 |
Grouped age | ||
Younger than 50 | 21 (55.3%) | 19 (59.4%) |
Older than 50 | 17 (44.7%) | 13 (40.6%) |
Body weight | ||
Mean | 68.1 kg | 69 kg |
Median | 65 kg | 70 kg |
Histology | ||
AA | 23 (60.5%) | 18 (56.2%) |
GBM | 15 (39.5%) | 14 (43.7%) |
KPS | ||
100 | 8 (21%) | 9 (28.1%) |
90 | 9 (23.6%) | 10 (31.2%) |
80 | 6 (15.8%) | 8 (25%) |
70 | 11 (28.9%) | 2 (6.2%) |
60 | 4 (10.5%) | 3 (9.3%) |
Previous surgery | ||
Total | 2 (5.4%) | 5 (17.2%) |
Partial | 27 (72.9%) | 14 (48.2%) |
Biopsy | 8 (21.6%) | 10 (34.5%) |